cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis
TNF-blocking agents treat rheumatoid arthritis and ankylosing spondylitis
October 25th, 2005
Tumor necrosis factor-blocking agents are effective in treating patients with rheumatoid arthritis and patients with ankylosing spondylitis. Researchers in Norway recently conducted a study "To compare the effectiveness of tumor necrosis factor (TNF)-blocking agents (etanercept and infliximab) in patients with rheumatoid arthritis (RA) and patients with ankylosing spondylitis (AS). Data from an ongoing longitudinal, observational study in Norway were used to assess changes in health-related quality of life (HRQOL) in patients with RA (n=291) and AS (n=62)." "Patients received anti-TNF therapy, and changes in scores on the Short Form 36 (SF-36),...
Source: cancer weekly (2005-10-25)
|
